| Catalog Number |
1000482 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Inflammation (1932)
|
| Date of Event |
03/17/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
A4, a5, and a6 are unknown.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by abiomed inc or its employees that the report constitutes an admission that the product, abiomed inc, or its employees, caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
| |
|
Event or Problem Description
|
|
An impella 5.5 device was inserted via the right axillary artery in a 41-year-old male patient presenting with acute myocardial infarction complicated by cardiogenic shock (ami/cgs), scai shock stage d.The patient's comorbidities were unknown.During support, contact tissue was noted around the graft entrance area.The introducer was removed at the conclusion of insertion according to protocol.No additional intervention was performed, and the patient remained on impella support.The reported inflammation may be consistent with localized tissue response at the graft or access site related to surgical manipulation and foreign-body contact in the setting of axillary implantation.
|
| |
|
Additional Manufacturer Narrative
|
|
Corrected information was provided in d3 (manufacturer fax).Upon review, it was identified that it was inadvertently omitted from the initial report.Corrected information was provided in d4 (catalog).Upon review, the section d catalog number has now been updated.H6: updated codes based on the results of the investigation.H11: updated based on the results of the investigation.The cause of the injury was not determined due to insufficient clinical details.
|
| |
|
Additional Manufacturer Narrative
|
|
The device has been returned for evaluation.The investigation is on-going.
|
| |
|
Additional Manufacturer Narrative
|
|
D9.Is device returned to manufacturer? and date device returned to manufacturer added.H6: investigation: type, findings, conclusion codes and h6 component codes were corrected accordingly based on the completed investigation.The device was returned for investigation.The cause of the injury was not determined due to insufficient clinical details.
|
| |
|
Search Alerts/Recalls
|